Holen Sie sich die Stockscreener-App
24.09
1.55%
-0.38
Vorhandelsmarkt:
24.14
0.05
+0.21%
Schlusskurs vom Vortag:
$24.47
Offen:
$24.25
24-Stunden-Volumen:
8.26M
Relative Volume:
0.88
Marktkapitalisierung:
$9.37B
Einnahmen:
$3.14B
Nettoeinkommen (Verlust:
$-3.36B
KGV:
-2.7595
EPS:
-8.73
Netto-Cashflow:
$-4.03B
1W Leistung:
-11.17%
1M Leistung:
-26.24%
6M Leistung:
-22.52%
1J Leistung:
-68.95%
1-Tages-Spanne:
$23.84
$24.38
1-Wochen-Bereich:
$23.84
$27.22
52-Wochen-Spanne:
$23.15
$79.96
Moderna Inc Stock (MRNA) Company Profile
Firmenname
Moderna Inc
Sektor
Branche
Telefon
(617) 714-6500
Adresse
325 BINNEY STREET, CAMBRIDGE
Vergleichen Sie MRNA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
MRNA
Moderna Inc
|
24.09 | 9.52B | 3.14B | -3.36B | -4.03B | -8.73 |
|
VRTX
Vertex Pharmaceuticals Inc
|
391.02 | 100.52B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
580.70 | 61.43B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
446.51 | 59.29B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
712.20 | 43.09B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
306.05 | 35.42B | 3.81B | -644.79M | -669.77M | -6.24 |
Moderna Inc Stock (MRNA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-13 | Eingeleitet | Citigroup | Neutral |
| 2025-02-18 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2025-01-29 | Herabstufung | Goldman | Buy → Neutral |
| 2024-12-18 | Herabstufung | Argus | Buy → Hold |
| 2024-12-10 | Fortgesetzt | BofA Securities | Underperform |
| 2024-11-19 | Eingeleitet | Berenberg | Hold |
| 2024-11-18 | Hochstufung | HSBC Securities | Hold → Buy |
| 2024-11-15 | Eingeleitet | Wolfe Research | Underperform |
| 2024-10-17 | Eingeleitet | Bernstein | Mkt Perform |
| 2024-09-13 | Herabstufung | JP Morgan | Neutral → Underweight |
| 2024-09-13 | Herabstufung | Jefferies | Buy → Hold |
| 2024-09-13 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2024-08-28 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2024-08-07 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2024-08-05 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-02-26 | Herabstufung | HSBC Securities | Hold → Reduce |
| 2024-01-02 | Hochstufung | Oppenheimer | Perform → Outperform |
| 2023-11-29 | Eingeleitet | Canaccord Genuity | Hold |
| 2023-11-03 | Hochstufung | HSBC Securities | Reduce → Hold |
| 2023-11-02 | Herabstufung | Deutsche Bank | Hold → Sell |
| 2023-08-04 | Herabstufung | TD Cowen | Outperform → Market Perform |
| 2023-08-03 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2023-07-24 | Eingeleitet | William Blair | Mkt Perform |
| 2023-07-14 | Eingeleitet | HSBC Securities | Reduce |
| 2023-06-26 | Hochstufung | UBS | Neutral → Buy |
| 2023-04-26 | Eingeleitet | Guggenheim | Neutral |
| 2023-03-13 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-03-02 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-24 | Herabstufung | SVB Securities | Market Perform → Underperform |
| 2022-12-19 | Hochstufung | Jefferies | Hold → Buy |
| 2022-12-14 | Herabstufung | Chardan Capital Markets | Buy → Neutral |
| 2022-10-21 | Hochstufung | SVB Leerink | Underperform → Mkt Perform |
| 2022-09-08 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2022-02-01 | Hochstufung | Redburn | Sell → Neutral |
| 2022-01-26 | Hochstufung | Deutsche Bank | Sell → Hold |
| 2022-01-21 | Hochstufung | BofA Securities | Underperform → Neutral |
| 2022-01-21 | Eingeleitet | UBS | Neutral |
| 2021-12-07 | Eingeleitet | Cowen | Market Perform |
| 2021-11-09 | Eingeleitet | Wolfe Research | Outperform |
| 2021-10-22 | Eingeleitet | Deutsche Bank | Sell |
| 2021-10-15 | Hochstufung | Piper Sandler | Neutral → Overweight |
| 2021-08-06 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2021-08-06 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2021-07-15 | Bestätigt | Jefferies | Hold |
| 2021-02-01 | Herabstufung | BofA Securities | Neutral → Underperform |
| 2020-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2020-12-16 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2020-12-09 | Herabstufung | Needham | Buy → Hold |
| 2020-11-23 | Eingeleitet | Wells Fargo | Equal Weight |
| 2020-11-17 | Herabstufung | BMO Capital Markets | Outperform → Market Perform |
| 2020-09-08 | Herabstufung | SVB Leerink | Mkt Perform → Underperform |
| 2020-07-23 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-07-20 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-07-13 | Eingeleitet | Jefferies | Buy |
| 2020-06-30 | Eingeleitet | Argus | Buy |
| 2020-06-08 | Eingeleitet | Barclays | Overweight |
| 2020-04-30 | Eingeleitet | BMO Capital Markets | Outperform |
| 2020-03-05 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2019-12-03 | Fortgesetzt | BofA/Merrill | Buy |
| 2019-10-25 | Eingeleitet | ROTH Capital | Buy |
| 2019-04-05 | Eingeleitet | Chardan Capital Markets | Buy |
Alle ansehen
Moderna Inc Aktie (MRNA) Neueste Nachrichten
FORA Capital LLC Boosts Holdings in Moderna, Inc. $MRNA - MarketBeat
Moderna (MRNA) Gains FDA Nod for Next-Gen COVID-19 Vaccine Targeting LP.8.1 Variant - Yahoo Finance
Is Moderna Inc. stock a value trapJuly 2025 Volume & Low Volatility Stock Recommendations - خودرو بانک
Dow Update: Is Moderna Inc. stock a value trapJuly 2025 Movers & Low Risk High Win Rate Stock Picks - خودرو بانک
What’s the outlook for Moderna Inc.’s sectorJuly 2025 Intraday Action & Stepwise Trade Execution Plans - خودرو بانک
Detecting support and resistance levels for Moderna Inc.July 2025 Short Interest & Weekly High Conviction Trade Ideas - Newser
Stock Analysis | Moderna OutlookNavigating Weak Technicals and Strong Fundamentals - AInvest
Can Traders Expect Breakout From Moderna Inc. This Week getLinesFromResByArray error: size == 0 - thegnnews.com
Robert Kennedy Jr.'s Leadership Can Only Bring More 'Harm,' Says Top Ex-CDC Official: 'Undoing Of Vaccination' In WorksModerna (NASDAQ:MRNA), BioNTech (NASDAQ:BNTX) - Benzinga
Moderna Inc. stock daily chart insightsPortfolio Risk Summary & Real-Time Chart Pattern Alerts - Newser
Aristides Capital LLC Acquires Shares of 20,000 Moderna, Inc. $MRNA - MarketBeat
Volume spikes in Moderna Inc. stock – what they meanWeekly Market Summary & Real-Time Market Sentiment Reports - Newser
Earnings visualization tools for Moderna Inc.July 2025 EndofMonth & Weekly Top Gainers Alerts - Newser
Has Moderna Inc. formed a bullish divergenceJuly 2025 Breakouts & AI Driven Stock Price Forecasts - Newser
What moving averages say about Moderna Inc.Trade Volume Report & Weekly High Potential Stock Alerts - Newser
Moderna (NASDAQ:MRNA) Trading Down 5.2% After Analyst Downgrade - MarketBeat
Moderna, Inc. $MRNA Shares Sold by Groupe la Francaise - MarketBeat
What data driven models say about Moderna Inc.’s future2025 Breakouts & Breakdowns & Technical Pattern Based Signals - Newser
Comparing Moderna Inc. in custom built stock radarsJuly 2025 PreEarnings & Capital Efficient Trading Techniques - Newser
Northern Trust Corp Boosts Stock Holdings in Moderna, Inc. $MRNA - MarketBeat
Published on: 2025-08-30 23:53:49 - Newser
Using flow based indicators on Moderna Inc.July 2025 Opening Moves & Entry and Exit Point Strategies - Newser
CDC sets return date for all employees after Aug. 8 shooting - Seeking Alpha
Short interest data insights for Moderna Inc.Quarterly Portfolio Report & Expert Approved Momentum Ideas - Newser
When is the best time to exit Moderna Inc.2025 Geopolitical Influence & Community Consensus Trade Signals - Newser
Moderna Inc. stock retracement – recovery analysisTrade Exit Report & Consistent Profit Alerts - Newser
Finanzdaten der Moderna Inc-Aktie (MRNA)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.96%
1.09%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):